In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors

Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom‐based study was completed, aimed at developing a system for measurement of anterior rectal wall doses during hypofractionated prostate stereotactic body radiotherapy (SBRT) utilizing tomotherapy delivery. An array of four dual MOSkin™ dosimeters, spaced 1 cm apart, was placed on a replica Rectafix® immobilization spacer device. This Perspex probe is a more rigid alternative to rectal balloons, to improve geometric reproducibility. The doses at each point were measured in real time and compared to doses calculated by the treatment planning system (TPS). Additionally, distance‐to‐agreement (DTA) measurements were acquired to assist in the comparison of measured and predicted doses. All dual MOSkin detectors measured dose to within ±5% of the TPS at the anterior rectal wall. Whilst several points were outside of experimental error, the largest deviation from the TPS predicted dose represented a DTA of only 1.3 mm, within the acceptable DTA tolerance of 3 mm. Larger deviations of up to −11.9% were observed for the posterior and side walls; however, if acceptable DTA measurements are accounted for, then an agreement of 75% was observed. Although larger differences were observed at the other rectal wall locations, the overall effect of dose at these points was not as significant, given the lower doses. Despite the very high‐dose gradient region, real‐time measurements of the anterior rectal wall doses were within acceptable limits of TPS‐predicted doses. The differences between measured and planned data were due to difficulties in precisely locating each detector on the TPS dose grid, which presented large variations in dose between CT voxels in regions of steep dose gradients. The dual MOSkin system would, therefore, be a useful device for detecting errors in real time, such as patient shifts or incorrect setup, during tomotherapy of the prostate. PACS numbers: 87.53.Ly, 87.55.km, 87.55.N‐

[1]  P. Deluca International Commission on Radiation Units and Measurements , 2013, Journal of the ICRU.

[2]  U. Isacsson,et al.  Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer , 2012, Prostate cancer.

[3]  K. Langen,et al.  SU-E-T-369: Evaluation of Dose Control System Performance on a TomoTherapy Hi-Art System , 2012 .

[4]  D. Waterhouse,et al.  Lack of backscatter factor measurements in HDR applications with MOSkins , 2011, Australasian Physical & Engineering Sciences in Medicine.

[5]  Aisling Haughey,et al.  Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy , 2011, Australasian Physical & Engineering Sciences in Medicine.

[6]  R. Berglund,et al.  A practical guide to prostate cancer diagnosis and management , 2011, Cleveland Clinic Journal of Medicine.

[7]  M. Santoro,et al.  Stereotactic Body Radiotherapy as Boost for Organ-confined Prostate Cancer , 2010, Technology in cancer research & treatment.

[8]  Anatoly Dritschilo,et al.  A Pilot Study of Intensity Modulated Radiation Therapy with Hypofractionated Stereotactic Body Radiation Therapy (SBRT) Boost in the Treatment of Intermediate- to High-Risk Prostate Cancer , 2010, Technology in cancer research & treatment.

[9]  W. Tomé,et al.  In vivo real-time rectal wall dosimetry for prostate radiotherapy , 2010, Physics in medicine and biology.

[10]  N. Papanikolaou,et al.  Impact of pulse forming network and injection current parameters on output and energy variations of helical tomotherapy. , 2010, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[11]  Ulf Isacsson,et al.  A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients , 2010, Acta oncologica.

[12]  J. Bucci,et al.  The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy. , 2008, Medical Physics (Lancaster).

[13]  M. Carolan,et al.  Comparison of the New MOSkin Detector and Fiber Optic Dosimetry System for Radiotherapy , 2008 .

[14]  M. Butson,et al.  Skin dosimetry with new MOSFET detectors , 2008 .

[15]  J. Lambert,et al.  In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector. , 2007, Medical physics.

[16]  T. Johnson Commissioning and Quality Assurance of Computerized Planning Systems for Radiation Treatment of Cancer , 2007 .

[17]  J. Seuntjens,et al.  Accurate skin dose measurements using radiochromic film in clinical applications. , 2006, Medical physics.

[18]  Robert Jeraj,et al.  Radiation characteristics of helical tomotherapy. , 2004, Medical physics.

[19]  J. Dempsey,et al.  Evaluation of the gamma dose distribution comparison method. , 2003, Medical physics.

[20]  A B Rosenfeld,et al.  MOSFET dosimetry on modern radiation oncology modalities. , 2002, Radiation protection dosimetry.

[21]  B Mijnheer,et al.  Tolerances for the accuracy of photon beam dose calculations of treatment planning systems. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  D. Low,et al.  A technique for the quantitative evaluation of dose distributions. , 1998, Medical physics.

[23]  Icrp ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection , 1991 .

[24]  R. M. Sievert,et al.  RECOMMENDATIONS OF THE INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION , 1959 .

[25]  I. Hsu,et al.  Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. , 2012, International journal of radiation oncology, biology, physics.